Abstract
Central serotonin-producing neurons are heterogeneous—differing in location, morphology, neurotoxin sensitivity and associated clinical disorders—but the underpinnings of this heterogeneity are largely unknown, as are the markers that distinguish physiological subtypes of serotonergic neurons. Here we redefined serotonergic subtypes on the basis of genetic programs that are differentially enacted in progenitor cells. We uncovered a molecular framework for the serotonergic system that, having genetic lineages as its basis, is likely to have physiological relevance and will permit access to genetically defined subtypes for manipulation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Paterson, D.S. et al. J. Am. Med. Assoc. 296, 2124–2132 (2006).
Riikonen, R.S. et al. Biol. Psychiatry 57, 1565–1572 (2005).
Pardo, C.A. & Eberhart, C.G. Brain Pathol. 17, 434–447 (2007).
Lidov, H.G. & Molliver, M.E. Brain Res. Bull. 8, 389–430 (1982).
Cordes, S.P. Clin. Genet. 68, 487–494 (2005).
Lumsden, A. & Krumlauf, R. Science 274, 1109–1115 (1996).
Farago, A.F. et al. Neuron 50, 205–218 (2006).
Awatramani, R. et al. Nat. Genet. 35, 70–75 (2003).
Dymecki, S.M. & Kim, J.C. Neuron 54, 17–34 (2007).
Kimmel, R.A. et al. Genes Dev. 14, 1377–1389 (2000).
Zervas, M. et al. Neuron 43, 345–357 (2004).
Simon, H.H. et al. Mol. Cell. Neurosci. 28, 96–105 (2005).
Voiculescu, O. et al. Genesis 26, 123–126 (2000).
Wallace, J.A. et al. Brain Res. Bull. 9, 117–129 (1982).
Scott, M.M. et al. J. Neurosci. 25, 2628–2636 (2005).
Acknowledgements
We thank A. Joyner, S. Schneider-Maunoury, and L. Sussel for mice (En1-cre, Egr2-cre and Nkx2.2+/−, respectively), and C. Cepko and L. Murtaugh for plasmids. We also thank members of the Dymecki lab and SIDS PPG (P01 HD036379) for input. This work was supported by grants from the US National Institutes of Health (P01 HD036379, R01 DK 067826 and R21 DA023643 to S.M.D., and R01 MH62723 to E.S.D.), the Charles H. Hood Foundation (P.J.) and the Charles King Trust Foundation (R.B.A.).
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1 and 2 (PDF 3497 kb)
Rights and permissions
About this article
Cite this article
Jensen, P., Farago, A., Awatramani, R. et al. Redefining the serotonergic system by genetic lineage. Nat Neurosci 11, 417–419 (2008). https://doi.org/10.1038/nn2050
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn2050
This article is cited by
-
Gut enterochromaffin cells drive visceral pain and anxiety
Nature (2023)
-
A CRISPR toolbox for generating intersectional genetic mouse models for functional, molecular, and anatomical circuit mapping
BMC Biology (2022)
-
Mafa-dependent GABAergic activity promotes mouse neonatal apneas
Nature Communications (2022)
-
5-HT modulation of a medial septal circuit tunes social memory stability
Nature (2021)
-
Dual recombinases-based genetic lineage tracing for stem cell research with enhanced precision
Science China Life Sciences (2021)